What is Peptide Receptor Radionuclide Therapy (PRRT)?
Peptide Receptor Radionuclide Therapy (PRRT) is a targeted molecular therapy used predominantly in the treatment of certain types of cancer, especially neuroendocrine tumors (NETs). This therapy involves the use of a small protein, or peptide, that is bound to a radioactive substance. The peptide specifically targets cancer cells that have an overexpression of certain receptors, allowing the radioactive substance to deliver a high dose of radiation directly to the cancer cells while sparing healthy tissue.
